NO20054615L - Mikrobolgemetode - Google Patents

Mikrobolgemetode

Info

Publication number
NO20054615L
NO20054615L NO20054615A NO20054615A NO20054615L NO 20054615 L NO20054615 L NO 20054615L NO 20054615 A NO20054615 A NO 20054615A NO 20054615 A NO20054615 A NO 20054615A NO 20054615 L NO20054615 L NO 20054615L
Authority
NO
Norway
Prior art keywords
mikrobolgemetode
pet
imaging
relates
present
Prior art date
Application number
NO20054615A
Other languages
English (en)
Other versions
NO332419B1 (no
Inventor
Irina Velikyan
Bengt Langstrom
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO20054615L publication Critical patent/NO20054615L/no
Publication of NO332419B1 publication Critical patent/NO332419B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nuclear Medicine (AREA)
  • Saccharide Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår en fremgangsmåte til fremstilling av radiomerkede galliumkomplekser som kan anvendes som diagnostiske midler agents, for eksempel ved posifron emisjons- tomografi (PET) bildefremstilling.
NO20054615A 2003-04-11 2005-10-07 Mikrobolgemetode NO332419B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0308408.4A GB0308408D0 (en) 2003-04-11 2003-04-11 Microwave activation
PCT/GB2004/001550 WO2004089425A1 (en) 2003-04-11 2004-04-08 Microwave method for preparing radiolabelled gallium complexes

Publications (2)

Publication Number Publication Date
NO20054615L true NO20054615L (no) 2005-10-07
NO332419B1 NO332419B1 (no) 2012-09-17

Family

ID=9956634

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054615A NO332419B1 (no) 2003-04-11 2005-10-07 Mikrobolgemetode

Country Status (19)

Country Link
US (1) US8007766B2 (no)
EP (1) EP1620134B1 (no)
JP (1) JP4814785B2 (no)
KR (1) KR101108420B1 (no)
CN (1) CN1771058B (no)
AT (1) ATE366122T1 (no)
AU (1) AU2004228746B2 (no)
BR (1) BRPI0409101A (no)
CA (1) CA2520653C (no)
DE (1) DE602004007371T2 (no)
ES (1) ES2288255T3 (no)
GB (1) GB0308408D0 (no)
IL (1) IL170864A (no)
MX (1) MXPA05010854A (no)
NO (1) NO332419B1 (no)
PL (1) PL1620134T3 (no)
RU (1) RU2333557C2 (no)
WO (1) WO2004089425A1 (no)
ZA (1) ZA200508727B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008531988A (ja) * 2005-02-22 2008-08-14 ジーイー・ヘルスケア・リミテッド 放射性標識ガリウム錯体、その合成法並びに悪性腫瘍におけるｅｇｆｒ発現のｐｅｔイメージングにおける使用
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
US8926945B2 (en) 2005-10-07 2015-01-06 Guerbet Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
US7586102B2 (en) 2006-08-14 2009-09-08 Board Of Regents The University Of Texas System Automated system for formulating radiopharmaceuticals
CN101528270A (zh) * 2006-08-28 2009-09-09 通用电气健康护理有限公司 基于68Ga标记的肽的放射性药物
US20100256331A1 (en) * 2006-08-29 2010-10-07 Ge Healthcare Limited 68Ga-Labelling of a Free and Macromolecule Conjugated Macrocyclic Chelator at Ambient Temperature
JP5088928B2 (ja) * 2006-11-24 2012-12-05 新日鐵化学株式会社 ８−オキシキノリン銅の製造方法
FR2942227B1 (fr) * 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
GB0922492D0 (en) * 2009-12-23 2010-02-03 Hammersmith Imanet Ltd Method for obtaining 68GA
ITFI20110180A1 (it) * 2011-08-12 2013-02-13 Advanced Accelerator Applic S A Processo per la preparazione di complessi di 68ga.
CN102965502A (zh) * 2011-09-01 2013-03-13 广西大学 一种分离富集镓的固相萃取法
BE1021191B1 (fr) 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
GB201814291D0 (en) * 2018-09-03 2018-10-17 Univ Oslo Process for the production of gallium radionculides
JPWO2023210510A1 (no) * 2022-04-27 2023-11-02

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932948C2 (de) * 1979-08-14 1982-11-18 Stiftung Deutsches Krebsforschungszentrum, 6900 Heidelberg Verfahren zur Herstellung eines Ionenaustauschers und dessen Verwendung
US5029065A (en) 1986-12-16 1991-07-02 Ciba-Geigy Corporation Control system for a sample preparation system
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
ATE203168T1 (de) * 1992-05-07 2001-08-15 Nycomed Imaging As Komplexbildnermittel und zielimmunoreagenzien
DE4231622C2 (de) * 1992-09-22 1996-09-05 Bakelite Ag Verfahren zur Herstellung von Metallneutralkomplexen mit hoher Koordinationszahl und deren Verwendung
WO1994017829A1 (en) * 1993-02-02 1994-08-18 Neorx Corporation Directed biodistribution of small molecules
BR9408590A (pt) * 1994-06-03 1997-08-26 Malinckrodt Medical Inc Agentes para imageamento ósseo rapidamente eliminaveis de fosfonato de tecnécio 99m
US6071490A (en) * 1998-05-07 2000-06-06 Immunomedics, Inc. Position emission tomography using gallium-68 chelates
WO1999056791A1 (en) * 1998-05-07 1999-11-11 The Research Foundation Of State University Of New York S3n radionuclide complexes
US7011816B2 (en) * 2001-12-26 2006-03-14 Immunomedics, Inc. Labeling targeting agents with gallium-68 and gallium-67

Also Published As

Publication number Publication date
RU2005130862A (ru) 2006-05-27
CA2520653C (en) 2012-06-05
WO2004089425A1 (en) 2004-10-21
BRPI0409101A (pt) 2006-04-04
JP4814785B2 (ja) 2011-11-16
KR20060006030A (ko) 2006-01-18
ZA200508727B (en) 2007-09-26
US8007766B2 (en) 2011-08-30
DE602004007371T2 (de) 2008-03-06
AU2004228746A1 (en) 2004-10-21
EP1620134A1 (en) 2006-02-01
CN1771058B (zh) 2010-05-26
RU2333557C2 (ru) 2008-09-10
ES2288255T3 (es) 2008-01-01
US20070027307A1 (en) 2007-02-01
JP2006522783A (ja) 2006-10-05
CA2520653A1 (en) 2004-10-21
ATE366122T1 (de) 2007-07-15
MXPA05010854A (es) 2005-12-14
NO332419B1 (no) 2012-09-17
PL1620134T3 (pl) 2007-11-30
GB0308408D0 (en) 2003-05-21
CN1771058A (zh) 2006-05-10
DE602004007371D1 (de) 2007-08-16
AU2004228746B2 (en) 2009-11-12
EP1620134B1 (en) 2007-07-04
KR101108420B1 (ko) 2012-01-30
IL170864A (en) 2010-05-31

Similar Documents

Publication Publication Date Title
BRPI0409101A (pt) método para produzir um complexo de gálio radiomarcado
BRPI0507684B8 (pt) agentes de contraste para imagem de perfusão miocárdica
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
EA201100301A1 (ru) Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения
IL183878A0 (en) Positron emission tomography imaging method
HUP0400253A2 (hu) Szilárd fázisú nukleofil fluorozás
SG152254A1 (en) Contrast agents for myocardial perfusion imaging
WO2001082864A3 (en) 18f-labeled choline analogs
NO20074576L (no) Radiolabeled Gallium Complexes, Methods for Synthesis and Use For Pet Imaging of EGFR Expression in Malignant Tumors
MX2011010295A (es) Reactivos de radiomarcado y metodos.
CY1106579T1 (el) Μεθοδος για την παρασκευη συμπλοκων 1,2-διαμινοκυκλοεξανιου-δισθενους πλατινης
WO2010096426A8 (en) Compounds, compositions, methods of synthesis, and methods of treatment
TW200738271A (en) Methods of making radiolabeled tracers and precursors thereof
UY30596A1 (es) Marcacion con fluor radioactivo
WO2008026051A3 (en) 68ga-labelling of a free and macromolecule conjugated macrocyclic chelator at ambient temperature
NZ591824A (en) Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
PL365279A1 (en) Biotin-derivates and their conjugates with chelating agents
EA200800948A1 (ru) Биотиндиаминопроизводные и их конъюгаты с макроциклическими хелатирующими реагентами
ATE521591T1 (de) 11c-markierte benzyl-lactam-verbindungen und deren verwendung als bildgebungsmittel
WO2005014479A3 (en) Process for preparing radiolabeled compounds
DE602005012376D1 (de) Neues 15o-markiertes monosaccharid und verfahren zu dessen herstellung
ITVE20040038A1 (it) Apparecchiatura per la produzione endogena di radioisotopi, particolarmente per diagnostica tomografica ad emissioni di positroni.
WO2009033584A3 (en) Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols
TW200744645A (en) Contrast agents for myocardium perfusion imaging
BR0302061A (pt) Complexos de metal de ácido 2-hidróxi-4-metiltiobutanóico para uso como alimento de animal

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees